Cargando…

Evaluating the Impact of Therapy on Quality of Life in Type 2 Diabetes: A Literature Review of Utilities Associated with Treatment-Related Attributes

INTRODUCTION: Treatment-related attributes and process characteristics such as dosing frequency, timing flexibility, ease of use of injection devices and unpleasant side-effects may have small but measurable effects on quality of life (QoL) in people with type 2 diabetes (T2D). A literature review w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Valentine, William, Norrbacka, Kirsi, Boye, Kristina Secnik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109803/ https://www.ncbi.nlm.nih.gov/pubmed/35586269 http://dx.doi.org/10.2147/PROM.S322390

Ejemplares similares

Evaluating health-related quality of life in type 1 diabetes: a systematic literature review of utilities for adults with type 1 diabetes
por: Smith-Palmer, Jayne, et al.
Publicado: (2016)

Patient preferences in Italy: health state utilities associated with attributes of weekly injection devices for treatment of type 2 diabetes
por: Matza, Louis S, et al.
Publicado: (2018)

Health state utilities associated with treatment process for oral and injectable GLP-1 receptor agonists for type 2 diabetes
por: Matza, Louis S., et al.
Publicado: (2021)

GLP-1 RA Treatment and Dosing Patterns Among Type 2 Diabetes Patients in Six Countries: A Retrospective Analysis of Pharmacy Claims Data
por: Divino, Victoria, et al.
Publicado: (2019)

GLP-1 RA Treatment Patterns Among Type 2 Diabetes Patients in Five European Countries
por: Divino, Victoria, et al.
Publicado: (2017)

Timing of GLP-1 Receptor Agonist Initiation for Treatment of Type 2 Diabetes in the UK
por: Boye, Kristina S., et al.
Publicado: (2019)

Treatment Patterns and Persistence With GLP-1 RA Treatments Among Patients With Type 2 Diabetes in France: A Retrospective Cohort Analysis
por: Zimner Rapuch, Sarah, et al.
Publicado: (2021)

Health state utilities associated with attributes of weekly injection devices for treatment of type 2 diabetes
por: Matza, Louis S., et al.
Publicado: (2017)

Treatment-Related Attributes of Diabetes Therapies and How People with Type 2 Diabetes Report Their Impact on Indicators of Medication-Taking Behaviors
por: Sims, Tracy J, et al.
Publicado: (2022)

Costs and where to find them: identifying unit costs for health economic evaluations of diabetes in France, Germany and Italy
por: Pöhlmann, J., et al.
Publicado: (2020)

Physician and patient management of type 2 diabetes and factors related to glycemic control in Spain
por: Yurgin, Nicole Rae, et al.
Publicado: (2008)

Associations between adherence and outcomes among older, type 2 diabetes patients: evidence from a Medicare Supplemental database
por: Boye, Kristina Secnik, et al.
Publicado: (2016)

The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES): Baseline Patient-Reported Outcomes
por: Boye, Kristina S., et al.
Publicado: (2020)

Patient-reported outcomes in a trial of exenatide and insulin glargine for the treatment of type 2 diabetes
por: Secnik Boye, Kristina, et al.
Publicado: (2006)

Utilization Patterns of Glucagon-Like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus in Italy: A Retrospective Cohort Study
por: Federici, Marco Orsini, et al.
Publicado: (2018)

The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES): Design and Baseline Characteristics
por: García-Pérez, Luis-Emilio, et al.
Publicado: (2021)

Utilization of diabetes medication and cost of testing supplies in Saskatchewan, 2001
por: Johnson, Jeffrey A, et al.
Publicado: (2006)

Relationship of Glycemic Control to Total Diabetes-Related Costs for Managed Care Health Plan Members With Type 2 Diabetes
por: Shetty, Sharashchandra, et al.
Publicado: (2005)

The Cost-effectiveness of Dulaglutide 1.5mg versus Exenatide QW for the Treatment of Patients with Type 2 Diabetes Mellitus in France
por: Basson, Mickael, et al.
Publicado: (2017)

Improved Glycaemic and Weight Management Are Associated with Better Quality of Life in People with Type 2 Diabetes Treated with Tirzepatide
por: Boye, Kristina S., et al.
Publicado: (2023)

Cost of medication adherence and persistence in type 2 diabetes mellitus: a literature review
por: Kennedy-Martin, Tessa, et al.
Publicado: (2017)

Glucagon-Like Peptide 1 Receptor Agonists in Type 2 Diabetes Mellitus: Data from a Real-World Study in Spain
por: Norrbacka, Kirsi, et al.
Publicado: (2021)

Which multi-attribute utility instruments are recommended for use in cost-utility analysis? A review of national health technology assessment (HTA) guidelines
por: Kennedy-Martin, Matthew, et al.
Publicado: (2020)

The longitudinal link between visual acuity and health-related quality of life in patients with diabetic retinopathy
por: Matza, Louis S, et al.
Publicado: (2008)

Validity and Reliability of the Assessment of Quality of Life (AQoL)-8D Multi-Attribute Utility Instrument
por: Richardson, Jeff, et al.
Publicado: (2013)

A utility valuation study assessing the impact of postprandial glucose control on quality of life of individuals with type 1 or type 2 diabetes
por: Jendle, J., et al.
Publicado: (2018)

Development of a Patient-Reported Outcome (PRO) Measure to Assess Emotional Impact of Treatment for Type 2 Diabetes
por: Boye, Kristina S., et al.
Publicado: (2023)

Fatigue in Type 2 Diabetes: Impact on Quality of Life and Predictors
por: Singh, Rupali, et al.
Publicado: (2016)

Quality of Life and Utility Values for Cost-Effectiveness Modeling in Japanese Patients with Type 2 Diabetes
por: Ishii, Hitoshi, et al.
Publicado: (2020)

The Utilization of Freezing Steps in Mesenchymal Stromal Cell (MSC) Manufacturing: Potential Impact on Quality and Cell Functionality Attributes
por: Oja, Sofia, et al.
Publicado: (2019)

Real-World Effectiveness of Dulaglutide in Patients with Type 2 Diabetes Mellitus: A Literature Review
por: Robinson, Susan, et al.
Publicado: (2020)

Impact of Diabetes Mellitus Type 1 on Lebanese Families’ Quality of Life
por: Noueiri, Balsam, et al.
Publicado: (2018)

Impact of Anti-Diabetic Medications on Quality of Life in Persons with Type 2 Diabetes Mellitus
por: Baruah, Manash P., et al.
Publicado: (2021)

Brazilian transgender children and adolescents: Attributes associated with quality of life
por: Nascimento, Fernanda Karla, et al.
Publicado: (2020)

Type 2 diabetes and quality of life
por: Trikkalinou, Aikaterini, et al.
Publicado: (2017)

Patient preferences for glucagon-like peptide 1 receptor–agonist treatment attributes
por: Thieu, Vivian T, et al.
Publicado: (2019)

Malnutrition, Its Attributes, and Impact on Quality of Life: An Epidemiological Study among β-Thalassemia Major Children
por: Biswas, Bijit, et al.
Publicado: (2021)

The association between diabetes related medical costs and glycemic control: A retrospective analysis
por: Oglesby, Alan K, et al.
Publicado: (2006)

Impact of pharmaceutical care on quality of life in patients with type 2 diabetes mellitus
por: Sriram, Shanmugam, et al.
Publicado: (2011)

The impact of comorbid chronic conditions on quality of life in type 2 diabetes patients
por: Adriaanse, Marcel C., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_p9ikq2ovsbuusen6usr2749525